ConductScience.org, home

Library / Genes

CEACAM3: CEA cell adhesion molecule 3

1 protein, 38 patents, 0 drugs, 0 trials, 3,674 NIH grants and 42,602 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCEACAM3HGNC
NameCEA cell adhesion molecule 3HGNC
NCBI Gene ID1084NCBI Gene
HGNC IDHGNC:1815HGNC
EnsemblENSG00000170956NCBI Gene
AliasesCD66D, CD66d, CEA, CGM1, CGM1a, W264, W282NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P40198Cell adhesion molecule CEACAM32524Ensembl, GeneID, HGNCUniProt

Patents 38

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2025539841 A2025-12-0965P40198Espacenet
JP 2025529142 A2025-09-04892P40198Espacenet
US 12371689 B22025-07-29892P40198Espacenet
JP 2025062604 A2025-04-1411939P40198Espacenet
JP 2024519078 A2024-05-0878P40198Espacenet
JP 2024508707 A2024-02-28254P40198Espacenet
US 11866495 B22024-01-09175P40198Espacenet
US 11773164 B22023-10-03175P40198Espacenet
JP 2022141755 A2022-09-29729P40198Espacenet
US 11446398 B22022-09-2011939P40198Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3674

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant2172,025NIH's project files
P30CA016672Cancer Center Support Grant1122,025NIH's project files
P30CA006973Regional Oncology Research Center592,025NIH's project files
P30CA033572Cancer Center Support Grant422,025NIH's project files
ZIABC010661Vaccine and Drug Combination Therapy for Human Cancers332,025NIH's project files
T32CA121938UCSD Cancer Center Training Program in Drug Development262,025NIH's project files
ZIABC010598Human Immune Responses to Tumor Antigens for Cancer Immunotherapy252,025NIH's project files
ZIABC010666Cancer Immunotherapy242,025NIH's project files
ZIABC010944Strategies for Cancer Immunotherapy Development: Preclinical Studies202,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant162,025NIH's project files

Papers 42602

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42822216PubTator, text miningPubMed
42802819PubTator, text miningPubMed
42798416PubTator, text miningPubMed
42798121PubTator, text miningPubMed
42796103PubTator, text miningPubMed
42794507PubTator, text miningPubMed
42790080PubTator, text miningPubMed
42786516PubTator, text miningPubMed
42781655PubTator, text miningPubMed
42780944PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license